Investorideas.com newswire, breaking biotechnology and pharma news

Friday, May 22, 2020

Investor Ideas Adds Recent IPO’s - Biotech (NYSE: $ADCT) (Nasdaq: $AYLA) (Nasdaq: $LYRA), Cloud (Nasdaq: $KC) and Gaming (Nasdaq: $GAN)


Investor Ideas Adds Recent IPO’s - Biotech (NYSE: $ADCT) (Nasdaq: $AYLA) (Nasdaq: $LYRA), Cloud (Nasdaq: $KC) and Gaming (Nasdaq: $GAN)








Point Roberts WA, Delta BC, May 22, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including biotech, cloud and gaming.


The latest company additions are all May IPO’s and are listed on the biotech, cloud and gaming directories.

New Stocks added to Biotech stocks directory
ADC Therapeutics SA (NYSE:ADCT) is a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent and targeted antibody drug conjugates (ADCs) for patients suffering from hematological malignancies and solid tumors. The Company develops ADCs by applying its decades of experience in this field and using next-generation pyrrolobenzodiazepine (PBD) technology to which ADC Therapeutics has proprietary rights for its targets. Strategic target selection for PBD-based ADCs and substantial investment in early clinical development have enabled ADC Therapeutics to build a deep clinical and research pipeline of therapies for the treatment of hematological and solid tumor cancers with significant unmet need. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase 2 clinical trials, in the USA and Europe, and numerous preclinical ADCs in development.

Ayala Pharmaceuticals, Inc. (NasdaqGS:AYLA) is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and preclinical studies underway in both solid tumors (AL101) and hematologic malignancies (AL102). Ayala’s lead product candidate, AL101, is currently in phase 2 for adenoid cystic carcinoma patients with tumor bearing Notch activating mutations  

Lyra Therapeutics, Inc. (NasdaqGM:LYRA) is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo™, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile. CRS is an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities and affects approximately 14 million people in the United States. The company is advancing LYR-210 as a potential preferred alternative to surgery in an ongoing Phase 2 clinical trial for CRS patients who have failed medical management. In its Phase 1 clinical trial, LYR-210 met its primary safety endpoint, and it was observed that patients generally experienced significant and rapid, clinically meaningful and durable improvement in SNOT-22 scores, an established patient symptom severity scale, through week 25, which was the end of the trial. The company is also developing LYR-220 for use in CRS patients who have an enlarged nasal cavity due to sinus surgery but continue to require treatment to manage CRS symptoms. Beyond CRS, the company believes its XTreo platform has potential applications in other disease areas, which it is actively exploring to further broaden the platform’s therapeutic potential.     

New Stocks added to Cloud stocks directory
Kingsoft Cloud Holdings Ltd (NasdaqGS:KC) is the largest independent cloud service provider in China. Kingsoft Cloud has built a comprehensive and reliable cloud platform consisting of extensive cloud infrastructure, cutting-edge cloud products and well-architected industry-specific solutions across public cloud, enterprise cloud and AIoT cloud services. As an independently operated company, Kingsoft Cloud is able to fully mobilize its resources towards the innovation of its business models and provide high-quality services to all kinds of businesses and organizations. With its focus squarely on its cloud business, Kingsoft Cloud is able to avoid potential conflicts of interest with its customers and enhance its neutral position, which in turn gains additional trust from more and more customers.

New Stocks added to Gaming stocks directory
GAN Ltd (NasdaqGS:GAN) is a leading business-to-business supplier of internet gambling software-as-a-service solutions predominantly to the U.S. land-based casino industry. GAN has developed a proprietary internet gambling enterprise software system, GameSTACK™, which it licenses to land-based casino operators as a turnkey technology solution for regulated real-money internet gambling, encompassing internet gaming, internet sports gaming and virtual Simulated Gaming.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.
We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  


Contact Investorideas.com
800 665 0411





Friday, May 8, 2020

New Telehealth/Telemedicine Stocks added to Investor Ideas Directories (NYSE: $ANTM) (NYSE: $CVS) (CSE: $BLR.C) (TSX: $WELL.TO)


New Telehealth/Telemedicine Stocks added to Investor Ideas Directories (NYSE: $ANTM) (NYSE: $CVS) (CSE: $BLR.C) (TSX: $WELL.TO)

Also new stocks in cannabis, gaming, sports and mining










Point Roberts WA, Delta BC, May 8, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including telehealth, cannabis, gaming, sports and mining.


A new section following stocks in the telehealth and telemedicine sector has been added to the biotech and tech stocks lists.  See the complete lists here:

The latest stocks in cannabis, gaming and sports and mining are all new CSE (Canadian Stock Exchange) listings.

New Stocks added to Telehealth on Biotech stocks directory and Tech stocks directory
Anthem Inc. (NYSE:ANTM) is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 108 million people, including more than 42 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.  Anthem delivers doctor visits to your phone through its telemedicine platform called LiveHealth

Blackhawk Growth Corp. (CSE: BLR; Frankfurt: 0JJ; OTC: BLRZF) is an investment issuer looking to capitalize on market and industry trends that can create substantial value for its shareholders. We look for opportunities all over the globe where we can leverage our knowledge, expertise, and experience to deliver substantial growth for our companies and our investors. Talk to Doc is an online telemedicine clinic and wellness brand that helps patients connect with doctors through an easy to use platform. www.talktodoc.ca will look to work directly with medical clinics and their doctors, in a range of specialties, with the ability to serve thousands of patients across Canada, providing a true stay-at-home solution for medical treatment nationwide.

CVS Health (NYSE:CVS) At CVS Health, we share a clear purpose: helping people on their path to better health. Through our health services, plans and community pharmacists, we’re pioneering a bold new approach to total health. Making quality care more affordable, accessible, simple and seamless, to not only help people get well, but help them stay well in body, mind and spirit. CVS Health is piloting several different telehealth opportunities, including making telehealth physician care accessible through CVS Health digital properties. CVS Health will also explore enabling MinuteClinic providers to consult with telehealth physicians to expand the scope of care offered at MinuteClinic. In addition, MinuteClinic will continue to provide telehealth care to patients in CVS retail stores and will explore serving as a site for in-person exams to facilitate telehealth medical visits.

WELL Health Technologies Corp. (TSX:WELL.TO) (OTC:WLYYF) is a unique company that operates Primary Healthcare Facilities, is the third largest Electronic Medical Records (EMR) supplier in Canada and is a provider of telehealth services.  WELL owns and operates 21 medical clinics, provides digital EMR software and services to over 1500 medical clinics across Canada and is a majority owner of SleepWorks Medical.  WELL's overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health.  WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL-T".  WELL was recognized as a TSX Venture 50 Company in 2018, 2019 and 2020. 

UnitedHealth Group Incorporated (NYSE:UNH) is a diversified health care company dedicated to helping people live healthier lives and helping to make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. Optum, our Health Services platform, is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities

Telus Health (TSX:T.TO)(NYSE:TU) together with its subsidiaries, provides a range of telecommunications products and services in Canada. It operates through Wireless and Wireline segments. Virtual Care Links: Akira by TELUS Health instantly connects employees and their family members to Canadian healthcare providers who can triage, diagnose, refer and provide prescriptions and medical advice related for a wide range of health concerns — whether employees are at home, at work or on vacation.  TELUS EMR Virtual Visit – an encrypted, EMR-integrated solution that enables virtual encounters by phone, text or video. Babylon by TELUS Health is a free app that allows you to receive virtual healthcare from your phone, without leaving the house.

Humana (NYSE:HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

Biotricity Inc. (OTCQB: BTCYis a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity’s R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system

Parallax Health Sciences, Inc. (OTC:PRLXis a leading-edge technology, outcome-driven telehealth company that allows for cost-effective remote diagnosis, treatment and monitoring of patients through proprietary platforms of integrated products and services. The Company's interoperable novel applications provide patients point-of-care testing and monitoring with information communicated via internet-based mobile phone applications that are agnostic as to operating system and are built on highly sophisticated data analytics. Information is retrieved real-time by physicians who are monitoring patients with chronic diseases or through biometric feedback for health-related behavior modification, and is automated for integration into electronic health records. The Company's products and offerings capitalize on the digital transformation in healthcare for improved patient compliance, diagnosis and treatment, and support healthcare system cost savings and efficiencies.

Protech Home Medical Corp. (TSXV:PTQ.V) provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

New Stocks added to Cannabis stocks directory
New Leaf Ventures Inc. (CSE:NLV) provides consulting services, real property, intellectual property, equipment for lease and enhanced ancillary services to a licensed cannabis producer and processor.

New Stocks added to Mining stocks directory
Origen Resources Inc. (CSE:ORGN) is a Vancouver, B.C. based mineral exploration company focused on generating, exploring and developing base and precious metal projects

FansUnite Entertainment Inc. (CSE:FANS) is a Sports and Entertainment company, focusing on technology related to regulated and lawful online sports betting, casino and other related products. The principal business will be operating the FansUnite B2C Sportsbook and the McBookie website, offering online sports betting and casino to the UK market. FansUnite is also a provider of technology solutions, products and services in the global gaming and entertainment industries and looks to acquire technology platforms and assets with high-growth potential in new or developing markets.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.
We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  


Contact Investorideas.com
800 665 0411